Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 06, 2018 08:00 ET | Source: Avinger, Inc.

Avinger to Announce Fourth Quarter 2017 and Full Year 2017 Results on March 19th, 2018

REDWOOD CITY, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it will...
March 05, 2018 08:00 ET | Source: Avinger, Inc.

Avinger Announces Participation in Cowen and Company 38th Annual Health Care Conference

REDWOOD CITY, Calif, March 05, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that the...
March 02, 2018 08:00 ET | Source: Avinger, Inc.

Avinger Regains Compliance with Nasdaq Listing Requirements

REDWOOD CITY, Calif., March 02, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced it has...
February 20, 2018 08:00 ET | Source: Avinger, Inc.

OPS Code Established for Peripheral Vascular OCT Imaging in Germany

REDWOOD CITY, Calif., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), announced that the German...
February 16, 2018 13:30 ET | Source: Avinger, Inc.

Avinger Announces Closing of $18 Million Underwritten Public Offering

REDWOOD CITY, Calif., Feb. 16, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced the closing of...
February 14, 2018 08:30 ET | Source: Avinger, Inc.

Avinger Announces Pricing of $18 Million Underwritten Public Offering

REDWOOD CITY, Calif., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced the pricing of...
February 02, 2018 08:00 ET | Source: Avinger, Inc.

Avinger’s Next Generation Pantheris Featured in Live Case Transmission at Leipzig Interventional Course 2018

REDWOOD CITY, Calif., Feb. 02, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), announced that its next...
January 30, 2018 16:45 ET | Source: Avinger, Inc.

Avinger Announces Reverse Stock Split

REDWOOD CITY, Calif., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that the...
January 19, 2018 08:00 ET | Source: Avinger, Inc.

Avinger Granted Continued Listing Decision From Nasdaq

REDWOOD CITY, Calif., Jan. 19, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), announced today that the...
January 03, 2018 08:30 ET | Source: Avinger, Inc.

Avinger Announces Treatment of First Patients Globally With Next Generation Pantheris

REDWOOD CITY, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), announced that Arne Schwindt,...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right